Albert David Limited (ALBERTDAVD.NS)
INR 851.7
(0.7%)
INR 851.7
(0.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.33 Billion INR | 10.54% |
| 2022 | 362.35 Million INR | 13.28% |
| 2021 | 319.88 Million INR | 193.02% |
| 2020 | 109.16 Million INR | -58.25% |
| 2019 | 261.45 Million INR | 14.86% |
| 2018 | 227.62 Million INR | 44.69% |
| 2017 | 157.32 Million INR | -22.3% |
| 2016 | 202.47 Million INR | -67.87% |
| 2015 | 630.18 Million INR | 210.91% |
| 2014 | 202.68 Million INR | 9.8% |
| 2013 | 184.6 Million INR | 37.92% |
| 2012 | 133.85 Million INR | 19.1% |
| 2011 | 112.38 Million INR | -31.5% |
| 2010 | 164.07 Million INR | 4.4% |
| 2009 | 157.16 Million INR | 28.98% |
| 2008 | 121.84 Million INR | 2.17% |
| 2007 | 119.25 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.06 Million INR | 296.53% |
| 2023 Q3 | 235.54 Million INR | -11.46% |
| 2023 Q4 | 77.39 Million INR | -67.14% |
| 2023 Q1 | 111.37 Million INR | 52.49% |
| 2023 Q2 | 266.04 Million INR | 138.88% |
| 2023 FY | 400.54 Million INR | 10.54% |
| 2022 Q1 | 100.94 Million INR | 32.4% |
| 2022 FY | 362.35 Million INR | 13.28% |
| 2022 Q2 | 257.09 Million INR | 154.68% |
| 2022 Q4 | 73.03 Million INR | -46.64% |
| 2022 Q3 | 136.85 Million INR | -46.77% |
| 2021 Q2 | 110.69 Million INR | 32.62% |
| 2021 Q4 | 76.24 Million INR | 54.08% |
| 2021 FY | 319.88 Million INR | 193.02% |
| 2021 Q1 | 83.46 Million INR | 77.87% |
| 2021 Q3 | 49.48 Million INR | -55.3% |
| 2020 Q3 | 36.3 Million INR | -60.34% |
| 2020 Q2 | 91.53 Million INR | 242.73% |
| 2020 Q1 | -64.13 Million INR | -1158.68% |
| 2020 FY | 109.16 Million INR | -58.25% |
| 2020 Q4 | 46.92 Million INR | 29.26% |
| 2019 Q4 | -5.09 Million INR | -110.5% |
| 2019 FY | 261.45 Million INR | 14.86% |
| 2019 Q1 | 115.04 Million INR | 26.2% |
| 2019 Q2 | 106.54 Million INR | -7.39% |
| 2019 Q3 | 48.53 Million INR | -54.45% |
| 2018 Q2 | 5.52 Million INR | -94.95% |
| 2018 Q4 | 91.16 Million INR | 261.78% |
| 2018 FY | 227.62 Million INR | 44.69% |
| 2018 Q1 | 109.54 Million INR | 5.55% |
| 2018 Q3 | 25.19 Million INR | 355.74% |
| 2017 Q2 | 129.41 Million INR | 207.13% |
| 2017 FY | 157.32 Million INR | -22.3% |
| 2017 Q4 | 103.78 Million INR | 56.63% |
| 2017 Q3 | 66.26 Million INR | -48.8% |
| 2017 Q1 | -120.8 Million INR | -262.34% |
| 2016 Q3 | -21.9 Million INR | -115.85% |
| 2016 FY | 202.47 Million INR | -67.87% |
| 2016 Q1 | 44.99 Million INR | -90.22% |
| 2016 Q2 | 138.2 Million INR | 207.17% |
| 2016 Q4 | 74.41 Million INR | 439.66% |
| 2015 Q3 | 13.32 Million INR | -87.49% |
| 2015 FY | 630.18 Million INR | 210.91% |
| 2015 Q1 | 50.52 Million INR | -14.73% |
| 2015 Q2 | 106.46 Million INR | 110.71% |
| 2015 Q4 | 459.86 Million INR | 3351.68% |
| 2014 Q3 | 10.53 Million INR | -89.92% |
| 2014 Q4 | 59.25 Million INR | 462.59% |
| 2014 Q2 | 104.46 Million INR | 267.44% |
| 2014 Q1 | 28.43 Million INR | -66.61% |
| 2014 FY | 202.68 Million INR | 9.8% |
| 2013 Q3 | -18.21 Million INR | -120.73% |
| 2013 Q4 | 85.14 Million INR | 567.46% |
| 2013 Q1 | 29.81 Million INR | -57.78% |
| 2013 FY | 184.6 Million INR | 37.92% |
| 2013 Q2 | 87.86 Million INR | 194.7% |
| 2012 Q1 | 22.06 Million INR | -66.64% |
| 2012 FY | 133.85 Million INR | 19.1% |
| 2012 Q4 | 70.62 Million INR | 255.01% |
| 2012 Q3 | -45.55 Million INR | -152.53% |
| 2012 Q2 | 86.73 Million INR | 293.14% |
| 2011 Q4 | 66.13 Million INR | 295.21% |
| 2011 FY | 112.38 Million INR | -31.5% |
| 2011 Q2 | 66.31 Million INR | 0.0% |
| 2011 Q3 | -33.87 Million INR | -151.08% |
| 2010 FY | 164.07 Million INR | 4.4% |
| 2009 FY | 157.16 Million INR | 28.98% |
| 2008 FY | 121.84 Million INR | 2.17% |
| 2007 FY | 119.25 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hester Biosciences Limited | 364.77 Million INR | -265.835% |
| Alembic Limited | 767.77 Million INR | -73.809% |
| Alkem Laboratories Limited | 19.46 Billion INR | 93.143% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 76.825% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -461.496% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| FDC Limited | 3.03 Billion INR | 56.013% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 85.138% |
| Gufic Biosciences Limited | 2.89 Billion INR | 53.886% |
| Hikal Limited | 1.49 Billion INR | 10.691% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 33.577% |
| Ind-Swift Limited | 1.22 Billion INR | -8.85% |
| Innova Captab Limited | 2.53 Billion INR | 47.326% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -523.462% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 74.283% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -541.412% |
| Laurus Labs Limited | 3.94 Billion INR | 66.204% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 29.999% |
| Lupin Limited | 27.75 Billion INR | 95.193% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -4759.993% |
| Medico Remedies Limited | 277.11 Million INR | -381.548% |
| Morepen Laboratories Limited | 4.17 Billion INR | 68.028% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 65.7% |
| Orchid Pharma Limited | 2.36 Billion INR | 43.481% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 52.101% |
| RPG Life Sciences Limited | 2.29 Billion INR | 41.785% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 134.635% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.721% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 71.038% |
| Themis Medicare Limited | 1.3 Billion INR | -2.406% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -21102.05% |
| Venus Remedies Limited | 534.65 Million INR | -149.594% |
| Wanbury Limited | 1.7 Billion INR | 21.834% |
| Windlas Biotech Limited | 1.29 Billion INR | -2.738% |
| ZIM Laboratories Limited | 1.09 Billion INR | -21.523% |
| Ipca Laboratories Limited | 29.59 Billion INR | 95.491% |
| Aarti Drugs Limited | 7.14 Billion INR | 81.333% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 57.34% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -6360.384% |
| Brooks Laboratories Limited | -72.25 Million INR | 1946.948% |
| Eris Lifesciences Limited | 5.18 Billion INR | 74.247% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 72.999% |
| Sigachi Industries Limited | 1.47 Billion INR | 9.461% |
| Sakar Healthcare Limited | 495.5 Million INR | -169.312% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 98.723% |
| Divi's Laboratories Limited | 18.31 Billion INR | 92.712% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 70.172% |
| Mankind Pharma Limited | 40.86 Billion INR | 96.735% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 5.31 Billion INR | 74.907% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 82.305% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 79.477% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 97.06% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -114.879% |
| Wockhardt Limited | 140 Million INR | -853.184% |
| Bal Pharma Limited | 214.56 Million INR | -521.924% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.03% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -8.404% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -141.93% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 81.531% |
| Shilpa Medicare Limited | 3.76 Billion INR | 64.524% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 93.218% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -47040.199% |
| Granules India Limited | 6.52 Billion INR | 79.559% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -435.387% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 94.733% |
| NATCO Pharma Limited | 25.96 Billion INR | 94.86% |
| Suven Life Sciences Limited | -1.22 Billion INR | 208.862% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 74.464% |
| Indoco Remedies Limited | 1.52 Billion INR | 12.46% |
| Alpa Laboratories Limited | 61.51 Million INR | -2069.32% |
| Lasa Supergenerics Limited | -458 Million INR | 391.363% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 132.429% |